mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.9 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.9 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |